Cargando…

Mind-controlled transgene expression by a wireless-powered optogenetic designer cell implant

Synthetic devices for traceless remote control of gene expression may provide new treatment opportunities in future gene- and cell-based therapies. Here we report the design of a synthetic mind-controlled gene switch that enables human brain activities and mental states to wirelessly programme the t...

Descripción completa

Detalles Bibliográficos
Autores principales: Folcher, Marc, Oesterle, Sabine, Zwicky, Katharina, Thekkottil, Thushara, Heymoz, Julie, Hohmann, Muriel, Christen, Matthias, Daoud El-Baba, Marie, Buchmann, Peter, Fussenegger, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Pub. Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241983/
https://www.ncbi.nlm.nih.gov/pubmed/25386727
http://dx.doi.org/10.1038/ncomms6392
_version_ 1782345924302864384
author Folcher, Marc
Oesterle, Sabine
Zwicky, Katharina
Thekkottil, Thushara
Heymoz, Julie
Hohmann, Muriel
Christen, Matthias
Daoud El-Baba, Marie
Buchmann, Peter
Fussenegger, Martin
author_facet Folcher, Marc
Oesterle, Sabine
Zwicky, Katharina
Thekkottil, Thushara
Heymoz, Julie
Hohmann, Muriel
Christen, Matthias
Daoud El-Baba, Marie
Buchmann, Peter
Fussenegger, Martin
author_sort Folcher, Marc
collection PubMed
description Synthetic devices for traceless remote control of gene expression may provide new treatment opportunities in future gene- and cell-based therapies. Here we report the design of a synthetic mind-controlled gene switch that enables human brain activities and mental states to wirelessly programme the transgene expression in human cells. An electroencephalography (EEG)-based brain–computer interface (BCI) processing mental state-specific brain waves programs an inductively linked wireless-powered optogenetic implant containing designer cells engineered for near-infrared (NIR) light-adjustable expression of the human glycoprotein SEAP (secreted alkaline phosphatase). The synthetic optogenetic signalling pathway interfacing the BCI with target gene expression consists of an engineered NIR light-activated bacterial diguanylate cyclase (DGCL) producing the orthogonal second messenger cyclic diguanosine monophosphate (c-di-GMP), which triggers the stimulator of interferon genes (STING)-dependent induction of synthetic interferon-β promoters. Humans generating different mental states (biofeedback control, concentration, meditation) can differentially control SEAP production of the designer cells in culture and of subcutaneous wireless-powered optogenetic implants in mice.
format Online
Article
Text
id pubmed-4241983
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Nature Pub. Group
record_format MEDLINE/PubMed
spelling pubmed-42419832014-12-04 Mind-controlled transgene expression by a wireless-powered optogenetic designer cell implant Folcher, Marc Oesterle, Sabine Zwicky, Katharina Thekkottil, Thushara Heymoz, Julie Hohmann, Muriel Christen, Matthias Daoud El-Baba, Marie Buchmann, Peter Fussenegger, Martin Nat Commun Article Synthetic devices for traceless remote control of gene expression may provide new treatment opportunities in future gene- and cell-based therapies. Here we report the design of a synthetic mind-controlled gene switch that enables human brain activities and mental states to wirelessly programme the transgene expression in human cells. An electroencephalography (EEG)-based brain–computer interface (BCI) processing mental state-specific brain waves programs an inductively linked wireless-powered optogenetic implant containing designer cells engineered for near-infrared (NIR) light-adjustable expression of the human glycoprotein SEAP (secreted alkaline phosphatase). The synthetic optogenetic signalling pathway interfacing the BCI with target gene expression consists of an engineered NIR light-activated bacterial diguanylate cyclase (DGCL) producing the orthogonal second messenger cyclic diguanosine monophosphate (c-di-GMP), which triggers the stimulator of interferon genes (STING)-dependent induction of synthetic interferon-β promoters. Humans generating different mental states (biofeedback control, concentration, meditation) can differentially control SEAP production of the designer cells in culture and of subcutaneous wireless-powered optogenetic implants in mice. Nature Pub. Group 2014-11-11 /pmc/articles/PMC4241983/ /pubmed/25386727 http://dx.doi.org/10.1038/ncomms6392 Text en Copyright © 2014, Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Folcher, Marc
Oesterle, Sabine
Zwicky, Katharina
Thekkottil, Thushara
Heymoz, Julie
Hohmann, Muriel
Christen, Matthias
Daoud El-Baba, Marie
Buchmann, Peter
Fussenegger, Martin
Mind-controlled transgene expression by a wireless-powered optogenetic designer cell implant
title Mind-controlled transgene expression by a wireless-powered optogenetic designer cell implant
title_full Mind-controlled transgene expression by a wireless-powered optogenetic designer cell implant
title_fullStr Mind-controlled transgene expression by a wireless-powered optogenetic designer cell implant
title_full_unstemmed Mind-controlled transgene expression by a wireless-powered optogenetic designer cell implant
title_short Mind-controlled transgene expression by a wireless-powered optogenetic designer cell implant
title_sort mind-controlled transgene expression by a wireless-powered optogenetic designer cell implant
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241983/
https://www.ncbi.nlm.nih.gov/pubmed/25386727
http://dx.doi.org/10.1038/ncomms6392
work_keys_str_mv AT folchermarc mindcontrolledtransgeneexpressionbyawirelesspoweredoptogeneticdesignercellimplant
AT oesterlesabine mindcontrolledtransgeneexpressionbyawirelesspoweredoptogeneticdesignercellimplant
AT zwickykatharina mindcontrolledtransgeneexpressionbyawirelesspoweredoptogeneticdesignercellimplant
AT thekkottilthushara mindcontrolledtransgeneexpressionbyawirelesspoweredoptogeneticdesignercellimplant
AT heymozjulie mindcontrolledtransgeneexpressionbyawirelesspoweredoptogeneticdesignercellimplant
AT hohmannmuriel mindcontrolledtransgeneexpressionbyawirelesspoweredoptogeneticdesignercellimplant
AT christenmatthias mindcontrolledtransgeneexpressionbyawirelesspoweredoptogeneticdesignercellimplant
AT daoudelbabamarie mindcontrolledtransgeneexpressionbyawirelesspoweredoptogeneticdesignercellimplant
AT buchmannpeter mindcontrolledtransgeneexpressionbyawirelesspoweredoptogeneticdesignercellimplant
AT fusseneggermartin mindcontrolledtransgeneexpressionbyawirelesspoweredoptogeneticdesignercellimplant